The|DET US_FDA|ENT had|VERB inspected|VERB unit-IV|PROPN ,|PUNCT where|ADV the|DET company|NOUN manufactures|VERB injectables|NOUN and|CCONJ ophthalmic_products|NOUN ,|PUNCT during|ADP 20-28|PERCENT April|PROPN .|PUNCT
Photo|NOUN :|PUNCT Bloomberg|ENT Mumbai|PROPN :|PUNCT The_US_Food_and_Drug_Administration|ENT (|PUNCT FDA|ENT )|PUNCT has|VERB issued|VERB form|NOUN 483|CARDINAL to|PART Aurobindo_Pharma_Ltd’s_unit-IV|PROPN in|ADP Hyderabad|ENT with|ADP seven|CARDINAL observations|NOUN relating|VERB to|ADP violation|NOUN of|ADP good_manufacturing_practices|NOUN ,|PUNCT according|VERB to|ADP information|NOUN on|ADP the|DET drug_regulator's_website|NOUN .|PUNCT
The_US|ENT FDA|ENT had|VERB inspected|VERB unit-IV|PROPN ,|PUNCT where|ADV the|DET company|NOUN manufactures|VERB injectables|NOUN and|CCONJ ophthalmic_products|NOUN ,|PUNCT during|ADP 20-28|PERCENT April|PROPN .|PUNCT
The_US|ENT FDA_issues|NOUN a|DET form|NOUN 483|CARDINAL if|ADP its|ADJ investigators|NOUN spot|VERB any|DET condition|NOUN that|ADP in|ADP their|ADJ judgement|NOUN may|VERB constitute|VERB violations|NOUN of|ADP the_US_Food_Drug_and_Cosmetic|ENT (|PUNCT FD&C|PROPN )|PUNCT Act|PROPN and|CCONJ related_Acts|PROPN .|PUNCT
At|ADP 11:45am|CARDINAL ,|PUNCT shares|NOUN of|ADP Aurobindo_Pharma|ENT were|VERB down|ADV 1.2%_to|PERCENT Rs596.15|VERB on|ADP the|DET BSE|ENT ,|PUNCT while|ADP the|DET benchmark_Sensex_index|NOUN was|VERB up|ADV 0.1%_at|PERCENT 29,949.69|CARDINAL points|NOUN .|PUNCT
Two|CARDINAL key_lapses|NOUN that|ADJ the|DET drug_regulator|NOUN observed|VERB at|ADP the|DET unit|NOUN were|VERB :|PUNCT Appropriate_controls|NOUN over|ADP computers|NOUN were|VERB not|ADV exercised|VERB to|PART ensure|VERB that|ADP changes|NOUN in|ADP master_production|NOUN and|CCONJ control_records|NOUN are|VERB instituted|VERB only|ADV by|ADP authorized_personnel|NOUN ,|PUNCT and|CCONJ procedures|NOUN designed|VERB to|PART prevent|VERB microbiological_contamination|NOUN of|ADP products|NOUN purporting|VERB to|PART be|VERB sterile|ADJ were|VERB not|ADV established|VERB .|PUNCT
The_US_FDA|ENT also|ADV observed|VERB that|ADP buildings|NOUN were|VERB not|ADV maintained|VERB in|ADP good_state|NOUN ,|PUNCT manufacturing_equipment|NOUN not|ADV maintained|VERB and|CCONJ appropriately|ADV designed|VERB to|PART achieve|VERB the|DET intended_purpose|NOUN ,|PUNCT laboratory_controls|NOUN did|VERB not|ADV include|VERB appropriate_test_procedures|NOUN ,|PUNCT changes|VERB to|ADP written_procedures|NOUN were|VERB not|ADV drafted|VERB ,|PUNCT reviewed|VERB and|CCONJ approved|VERB by|ADP the|DET appropriate_unit|NOUN and|CCONJ batch_distribution|NOUN not|ADV reviewed|VERB thoroughly|ADV .|PUNCT
The|DET issues|NOUN highlighted|VERB by|ADP the|DET US_FDA|ENT at|ADP the|DET unit|NOUN do|VERB not|ADV appear|VERB to|PART be|VERB very|ADV severe|ADJ and|CCONJ the|DET company|NOUN will|VERB be|VERB able|ADJ to|PART address|VERB them|PRON soon|ADV ,|PUNCT a|DET research_analyst|NOUN at|ADP a|DET domestic_brokerage_house|NOUN ,|PUNCT who|NOUN did|VERB not|ADV wish|VERB to|PART be|VERB named|VERB ,|PUNCT said|VERB .|PUNCT
According|VERB to|ADP Aurobindo_Pharma|ENT ,|PUNCT product_filings|NOUN with|ADP the|DET US_FDA|ENT from|ADP unit|NOUN -|PUNCT IV|PROPN were|VERB 75|CARDINAL as|ADV on|ADP 31_December_2016|DATE ,|PUNCT of|ADP which|ADJ the|DET company|NOUN has|VERB got|VERB marketing_approval|NOUN for|ADP 38|CARDINAL products|NOUN .|PUNCT
On|ADP 19_April_2017|DATE ,|PUNCT the|DET US_FDA|ENT had|VERB issued|VERB form|NOUN 483|CARDINAL to|ADP the|DET company’s_unit|NOUN -|PUNCT III|PROPN in|ADP Hyderabad|ENT ,|PUNCT used|VERB for|ADP manufacturing|VERB oral_formulations|NOUN ,|PUNCT with|ADP six|CARDINAL observations|NOUN relating|VERB to|ADP violation|NOUN of|ADP norms|NOUN .|PUNCT
